Oric Pharmaceuticals's total assets for Q2 2025 were $346.86M, an increase of 42.82% from the previous quarter. ORIC total liabilities were $22.86M for the fiscal quarter, a -1.12% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.